SCHEMBL4182988

SCHEMBL4182988

CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR5A2 O00482 2/20 0.83
NR5A1 Q13285 2/20 0.83
SMN1; SMN2 Q16637 1/20 0.83
ALDH1A1 P00352 1/20 0.83
MAPT P10636 1/20 0.74
RECQL P46063 1/20 0.66
FABP3 P05413 1/20 0.66
SELP P16109 1/20 0.61
S1PR1 P21453 1/20 0.56
ADRA1D P25100 1/20 0.56
PTAFR P25105 1/20 0.56
HTR1D P28221 1/20 0.56
HTR2C P28335 1/20 0.56
ADRA1B P35368 1/20 0.56
DRD3 P35462 1/20 0.56
TMEM97 Q5BJF2 1/20 0.56
PRKCE Q02156 1/20 0.55
PRKCQ Q04759 1/20 0.55
PRKCD Q05655 1/20 0.55
PRKCA P17252 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31276170 1.00 NR5A2 (0.83) NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL10498201 1.00 NR5A2 (0.83) NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL31084795 1.00 NR5A2 (0.83) NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL13735582 1.00 NR5A2 (0.83) NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL234615 1.00 NR5A2 (0.83) NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL23834444 1.00 NR5A2 (0.83) NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL3730490 1.00 NR5A2 (0.83) NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL233018 1.00 NR5A2 (0.83) NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL25777 1.00 NR5A2 (0.83) NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT
SCHEMBL31695681 1.00 NR5A2 (0.83) NR5A2NR5A1SMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090036410-A1 Structured Phospholipids BTG INTERNATIONAL LIMITED (GB) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036410-A1 Structured Phospholipids SGMS1, SGMS2, SMPD1 NR5A2 3152/4885NR5A1 1440/4885SMN1; SMN2 905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.